UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901

Bioorganic & medicinal chemistry, 2008-12, Vol.18 (24), p.6501-6504

2008

Volltextzugriff (PDF)

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (20), p.12022-12027

1998

Volltextzugriff (PDF)

Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved

Drug metabolism and disposition, 2004-06, Vol.32 (6), p.639-646

2004

Volltextzugriff (PDF)

A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase

Science (American Association for the Advancement of Science), 1994-08, Vol.265 (5175), p.1093-1095

1994

Volltextzugriff (PDF)

Biolayer Interferometry Assay for Cyclin-Dependent Kinase-Cyclin Association Reveals Diverse Effects of Cdk2 Inhibitors on Cyclin Binding Kinetics

ACS chemical biology, 2023-02, Vol.18 (2), p.431-440

2023

Volltextzugriff (PDF)

Chemical Inhibitors of Protein Kinases

Chemical reviews, 2001-08, Vol.101 (8), p.2541-2572

Bridges, Alexander J

2001

Volltextzugriff (PDF)

Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?

Oncotarget, 2021-05, Vol.12 (11), p.1032-1036

2021

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor

Journal of medicinal chemistry, 2001-02, Vol.44 (3), p.429-440

2001

Volltextzugriff (PDF)

Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor

Journal of medicinal chemistry, 1995-09, Vol.38 (18), p.3482-3487

1995

Volltextzugriff (PDF)

Disruptin, a cell-penetrating peptide degrader of EGFR: Cell-Penetrating Peptide in Cancer Therapy

Translational oncology, 2021-08, Vol.14 (8), p.101140-101140

2021

Volltextzugriff (PDF)

Disruptin, a cell-penetrating peptide degrader of EGFR

Translational oncology, 2021-08, Vol.14 (8), p.101140, Article 101140

2021

Volltextzugriff (PDF)

A Synthetic Inhibitor of the Mitogen-Activated Protein Kinase Cascade

Proceedings of the National Academy of Sciences - PNAS, 1995-08, Vol.92 (17), p.7686-7689

1995

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors. 10. Isomeric 4-[(3-Bromophenyl)amino]pyrido[d]- pyrimidines Are Potent ATP Binding Site Inhibitors of the Tyrosine Kinase Function of the Epidermal Growth Factor Receptor

Journal of medicinal chemistry, 1996-04, Vol.39 (9), p.1823-1835

1996

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors

Journal of medicinal chemistry, 2006-02, Vol.49 (4), p.1475-1485

2006

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor

Journal of medicinal chemistry, 1996-01, Vol.39 (1), p.267-276

1996

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors. 16. 6,5,6-Tricyclic Benzothieno[3,2-d]pyrimidines and Pyrimido[5,4-b]- and -[4,5-b]indoles as Potent Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase

Journal of medicinal chemistry, 1999-12, Vol.42 (26), p.5464-5474

1999

Volltextzugriff (PDF)

Editorial Oncologic, Endocrine & Metabolic: The current status of tyrosine kinase inhibitors: Do the diarylamine inhibitors of the EGF receptor represent a new beginning?

Expert opinion on therapeutic patents, 1995-12, Vol.5 (12), p.1245-1257

Bridges, Alexander J

1995

Volltextzugriff (PDF)

Synthesis and structure–activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4- c]carbazole-1,3(2 H,6 H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases

European journal of medicinal chemistry, 2008-06, Vol.43 (6), p.1276-1296

2008

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors. 9. Synthesis and Evaluation of Fused Tricyclic Quinazoline Analogues as ATP Site Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor

Journal of medicinal chemistry, 1996-02, Vol.39 (4), p.918-928

1996

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors. 12. Synthesis and Structure−Activity Relationships for 6-Substituted 4-(Phenylamino)pyrimido[5,4-d]pyrimidines Designed as Inhibitors of the Epidermal Growth Factor Receptor

Journal of medicinal chemistry, 1997-06, Vol.40 (12), p.1820-1826

1997

Volltextzugriff (PDF)

Tyrosine kinase inhibitors. 7. 7-amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor

Journal of medicinal chemistry, 1995-09, Vol.38 (19), p.3780-3788

1995

Volltextzugriff (PDF)

Biochemical and antiproliferative properties of 4-[Ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor

Biochemical pharmacology, 1997-10, Vol.54 (8), p.877-887

1997

Volltextzugriff (PDF)

Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines : an important new class of selective synthetic urokinase inhibitor

Cancer research (Chicago, Ill.), 1993-06, Vol.53 (11), p.2553-2559

1993

Volltextzugriff (PDF)

Inhibitors of protein tyrosine kinases

Current opinion in biotechnology, 1995, Vol.6 (6), p.662-667

1995

Volltextzugriff (PDF)

STRUCTURE-ACTIVITY RELATIONSHIPS FOR 4-ANILINOQUINAZOLINES AS POTENT INHIBITORS AT THE ATP BINDING SITE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN VITRO

Clinical and experimental pharmacology & physiology, 1996-05, Vol.23 (5), p.424-427

1996

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(198)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Englisch
(213)

Erscheinungsjahr

n.n

Thema

Science & Technology
(147)
Life Sciences & Biomedicine
(96)
Humans
(90)
Female
(56)
Male
(56)
Biological And Medical Sciences
(36)
Animals
(33)
Medical Sciences
(31)
Physical Sciences
(28)
Infant, Newborn
(27)
Adult
(24)
Chemistry
(24)
Pediatrics
(23)
Pharmacology & Pharmacy
(21)
Science & Technology - Other Topics
(21)
Multidisciplinary Sciences
(20)
Structure-Activity Relationship
(18)
Middle Aged
(17)
Chemistry, Medicinal
(16)
General & Internal Medicine
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved

A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase

Biolayer Interferometry Assay for Cyclin-Dependent Kinase-Cyclin Association Reveals Diverse Effects of Cdk2 Inhibitors on Cyclin Binding Kinetics

Chemical Inhibitors of Protein Kinases

Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?

Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor

Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor

Disruptin, a cell-penetrating peptide degrader of EGFR: Cell-Penetrating Peptide in Cancer Therapy

Disruptin, a cell-penetrating peptide degrader of EGFR

A Synthetic Inhibitor of the Mitogen-Activated Protein Kinase Cascade

Tyrosine Kinase Inhibitors. 10. Isomeric 4-[(3-Bromophenyl)amino]pyrido[d]- pyrimidines Are Potent ATP Binding Site Inhibitors of the Tyrosine Kinase Function of the Epidermal Growth Factor Receptor

Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors

Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor

Tyrosine Kinase Inhibitors. 16. 6,5,6-Tricyclic Benzothieno[3,2-d]pyrimidines and Pyrimido[5,4-b]- and -[4,5-b]indoles as Potent Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase

Editorial Oncologic, Endocrine & Metabolic: The current status of tyrosine kinase inhibitors: Do the diarylamine inhibitors of the EGF receptor represent a new beginning?

Synthesis and structure–activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4- c]carbazole-1,3(2 H,6 H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases

Tyrosine Kinase Inhibitors. 9. Synthesis and Evaluation of Fused Tricyclic Quinazoline Analogues as ATP Site Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor

Tyrosine Kinase Inhibitors. 12. Synthesis and Structure−Activity Relationships for 6-Substituted 4-(Phenylamino)pyrimido[5,4-d]pyrimidines Designed as Inhibitors of the Epidermal Growth Factor Receptor

Tyrosine kinase inhibitors. 7. 7-amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor

Biochemical and antiproliferative properties of 4-[Ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor

Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines : an important new class of selective synthetic urokinase inhibitor

Inhibitors of protein tyrosine kinases

STRUCTURE-ACTIVITY RELATIONSHIPS FOR 4-ANILINOQUINAZOLINES AS POTENT INHIBITORS AT THE ATP BINDING SITE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN VITRO

Suchergebnisse filtern